offers a simplified yet highly effective way of diagnosing early, when recovery rates are high. Our ® uses light to diagnose tissue health. In fact, our patented technology instantly detects if tissue is normal, pre-cancerous or cancerous without the need for a costly physical biopsy.

According to the , over 140,000 new cases of colorectal cancer are expected in the US this year alone. This dreaded disease is the second leading cause of cancer-related deaths in the US (after lung cancer), and the third most common cancer overall. Only 39% of colorectal cancers are detected at an early stage.

 

website:www.spectrascience.com

Tags

 
 
 
 

Enjoy this site? Please spread the word :)

RSS
EMAIL
SHARE